News
News
2024-11-14
The 2024 National Marine Medicine and Biological Products Industry Alliance Annual Meeting, under the guidance of the Marine Strategic Planning and Economic Department of the Ministry of Natural Resources, was successfully concluded by the vice chairman units of the alliance, Ningbo Xinoya Marine Biotechnology Co., Ltd. and Qingdao Mingyue Seaweed Group Co., Ltd. The annual meeting is themed "Sharing, Innovation, and Change". Meng Qinglei, Deputy Director of the Marine Strategic Planning and Economic Department of the Ministry of Natural Resources, Lin Huaiyuan, member of the Party Group and second level inspector of the Xiamen Ocean Development Bureau, and Lin Longshan, Deputy Director of the Third Institute of Oceanography of the Ministry of Natural Resources, attended and delivered speeches. In the agenda of the annual meeting, the "Forum on High Quality Development of Marine Drugs and Biological Products Industry", special reports were made on topics such as "Integration and Innovation of Marine Drugs, Bioeconomy and Deep Sea Biological Resources, Development of Active Peptide Industry, and Investment Prospects of Biomedical Industry". The current annual meeting also reviewed and approved the "Management Measures for Member Licensing of the National Marine Drug and Biological Products Industry Alliance (Trial)". Ningbo Xinuoya Marine Biotechnology Co., Ltd. will always adhere to the responsibilities of the "National Marine Medicine Alliance Unit", and under the guidance of the Third Institute of Oceanography of the Ministry of Natural Resources, we will unwaveringly persist in scientific research and exploration in the field of marine biology, develop new quality productivity, and be a "vanguard" for "Made in China" marine biological products to enter the international market!
Learn More +
Microcrystalline ball probiotics are low-temperature non-invasive "core" ball technology
2024-06-19
As the "second brain of the human body", the health of the intestine is closely related to the overall health of the human body. At present, probiotic dietary supplements are receiving more and more attention and attention. In 2020, the "Expert Consensus on the Clinical Application of Chinese Microecological Regulators (2020 Edition)" issued by the Microecology Branch of the Chinese Preventive Medicine Association pointed out that the effect of probiotics is strain-specific and dose-dependent, and the supplemental dose of probiotics is usually limited to the range of 108-1011 CFU. However, the fragile physiological and biochemical properties of probiotics make them intolerant to multiple factors such as temperature, moisture, and gastric digestive environment, which ultimately affects the stability of the product and its effect. Therefore, the development of new complex preparations of probiotics that can deliver high viable counts to the intestine plays an important role in improving product quality and enhancing product value.
Learn More +
Contact us
Any information
Manufacturer Address
No.5,Rongtai Road,Chengdong Industry Park, Ningbo,Zhejiang,China
R&D Center Address
7th Floor, No.1299 JuXian Rd,Yin Zhou District, Ningbo,Zhejiang,China
NEWGEN BIOTECH USA INC.
12901 Nicholson Rd, Suite100 Farmers Branch (Dallas),Texas 75234
